Literature DB >> 16847584

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.

Christopher R Chapple1, Linda Brubaker, François Haab, Philip van Kerrebroeck, Dudley Robinson.   

Abstract

Intervention for stress urinary incontinence (SUI) is generally focused on minimizing urinary leakage. However, the overall impact of SUI therapy on patients' quality of life is, arguably, more important than leakage outcomes. We performed a literature search to investigate the effect of urethral injection therapy on quality of life. Significant quality-of-life improvements have been observed with a number of injectable agents, while there is a distinct lack of correlation between subjective and objective outcomes. Two studies comparing urethral injection therapy with surgical intervention found superior objective efficacy with surgery, but no significant differences in quality-of-life improvements. Personal goals of patients undergoing urethral injection are yet to be explored, but there may be willingness to trade a lower success rate in favor of a more minor treatment procedure. In conclusion, quality-of-life improvements after urethral injection appear significant and comparable to those obtained with surgery. Further study of patients' own perceptions, pre- and posttreatment, would be valuable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847584     DOI: 10.1007/s00192-006-0148-0

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  34 in total

1.  Results of transurethral injection of silicone micro-implants for females with intrinsic sphincter deficiency.

Authors:  E Barranger; X Fritel; O Kadoch; Y Liou; A Pigné
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

Review 2.  Stress incontinence injection therapy: what is best for our patients?

Authors:  Christopher R Chapple; Alan J Wein; Linda Brubaker; Roger Dmochowski; Montserrat Espuña Pons; François Haab; Simon Hill
Journal:  Eur Urol       Date:  2005-10       Impact factor: 20.096

3.  Periurethral collagen injection for stress incontinence with and without urethral hypermobility.

Authors:  A C Steele; N Kohli; M M Karram
Journal:  Obstet Gynecol       Date:  2000-03       Impact factor: 7.661

4.  Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases.

Authors:  E C Janowsky; L L Kupper; B S Hulka
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

5.  Endoscopic evacuation of Durasphere.

Authors:  Victor H Hartanto; Deborah J Lightner; Victor W Nitti
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

6.  Macroplastique implantation system for the treatment of female stress urinary incontinence.

Authors:  José Tadeu Nunes Tamanini; Carlos Arturo Levi D'Ancona; Valdir Tadini; Nelson Rodrigues Netto
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

7.  Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup.

Authors:  K L Chrouser; F Fick; A Goel; N B Itano; S D Sweat; D J Lightner
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.

Authors:  F Bano; J W Barrington; R Dyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-09-18

9.  Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery.

Authors:  Sangeeta T Mahajan; Eman A Elkadry; Kimberly S Kenton; Susan Shott; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2006-03       Impact factor: 8.661

Review 10.  Injectable agents: present and future.

Authors:  Deborah J Lightner; Nancy B Itano; Susan D Sweat; Kristin L Chrouser; Felecia Fick
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

View more
  6 in total

1.  Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.

Authors:  Ha Na Lee; Young-Suk Lee; Ji-Yeon Han; Jae Yong Jeong; Myung-Soo Choo; Kyu-Sung Lee
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

2.  Combined trans- and periurethral injections of bulking agents for the treatment of intrinsic sphincter deficiency.

Authors:  Eric R Sokol; Vivian C Aguilar; Vivian W Sung; Deborah L Myers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-27

3.  Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence.

Authors:  Gerda Trutnovsky; Karl Tamussino; Elfriede Greimel; Vesna Bjelic-Radisic
Journal:  Int Urogynecol J       Date:  2010-10-09       Impact factor: 2.894

Review 4.  Urethral bulking agents: techniques and outcomes.

Authors:  Ahmed F Kotb; Lysanne Campeau; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

5.  Goal achievement as a patient-generated outcome measure for stress urinary incontinence.

Authors:  Jill L Milne; Magali Robert; Selphee Tang; Neil Drummond; Sue Ross
Journal:  Health Expect       Date:  2009-09       Impact factor: 3.377

6.  Safety and efficacy of polydimethylsiloxane (Macroplastique®) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up.

Authors:  Gamal Ghoniem; Bilal Farhan; Mashrin Lira Chowdhury; Yanjun Chen
Journal:  Int Urogynecol J       Date:  2021-06-08       Impact factor: 2.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.